
Integration Activation Pack
Global Health Industries Big Bet
2023
Work in Progress
With our global deals capabilities we are able to support our clients with any transaction - Pharma Lifescience (PLS) and Healthcare Services (HCS) M&A.
Our extensive portfolio of industry-focused deals services starting from the first strategic considerations and scoping of a target to the intense planning phase between Signing and Closing, to the first 100 days of supporting the integration.
Especially when planning transactions in the highly regulated and thus complex environment our digital tools help us along the deal cycle and make processes more efficient by e.g., automating planning and aligning regulatory and production timelines.
With our PE Roll-up expertise we accommodate the requirements of routined deal maker clients to create scalable platforms that drive value creation when following their buy-&-build strategy.

Savvy health industry dealmakers who can navigate a tricky regulatory and macroeconomic landscape will continue to use M&A to innovate, grow in line with enterprise priorities and implement strategic portfolio measures. This way, they will stay ahead of their competitors.
Christian K. Moldt
Global Health Industries Deals Leader, Partner, PwC Germany
Your Health Industries Integration Expert

Bobby Shuman
Big Bet Expert Integrations US
robert.g.shuman@pwc.com
+1 404-667-8575

Sky Milch
Big Bet Expert Integrations US
sky.milch@pwc.com
+1 917-312-1960

Christian Moldt
Big Bet Expert Integrations EMEA
christian.moldt@pwc.com
+49 1511 7604741

Rick van Dommelen
Big Bet Expert Integrations APAC
rick.van.dommelen@pwc.com
+31 6 51607076
Conversation starters which achieve seamless integration and deal success within the evolving Health Industries

Market trends
The landscape of megadeals is being impacted by increased antitrust scrutiny from regulators, making the completion of transformative deals more challenging.
As the valuation gap narrows, a notable upswing in deal activity during the second half of the year is anticipated.
To surpass the terminal value of your business and achieve higher deal volumes, it is imperative to develop a compelling value creation strategy. Additionally, ensuring a seamless integration process that prioritizes business continuity becomes crucial for long-term success.

Health Industries
Health Industries are experiencing significant pressure as major Pharma companies face the looming challenge of patent cliffs in the back half of the decade, necessitating urgent actions to fill their pipelines and ensure future revenue streams.
Private equity firms are actively seeking opportunities to deploy their available funds by acquiring innovative healthcare assets, indicating a heightened demand for strategic investments in the industry.
Successful integrations in Health Industries require careful planning, alignment of strategies, and effective execution to maximize value creation potential in a complex regulatory and market landscape.

PwC comments
Experience an in-depth understanding to derive a clear roadmap and value creation path remains essential to make your integration successful - regardless if transformational, absorption, tuck in, or standalone.
We have seen the most successful integrations in the industry - but we have also observed how others failed or at least fell short of the expected results.
Through an early but functionally vetted integration strategy, the ability to adjust and fine tune over the course of the program, and by tracking clearly against pre-defined KPIs, we have seen integrations strive.
You will need to prepare your organization to realistically spend anything between 6-10% of the deal volume on integration.
Learn more about the other Big Bets
© 2023 PwC. All rights reserved. PwC refers to the PwC network and/or one or more of its member firms, each of which is a separate legal entity. Please see www.pwc.com/structure for further details.

Christian Moldt
Client Relationship Partner BioNTech
Dear Team,
Hey, you just created a text paragraph! Somebody once said that the pen is mightier than the sword — and that was in 1839. Just imagine, with the power of cutting-edge content experiences and the ability to distribute your content around the world in mere seconds, writing this paragraph could be one of the most influential things you ever do!
Hey, you just created a text paragraph! Somebody once said that the pen is mightier than the sword — and that was in 1839. Just imagine, with the power of cutting-edge content experiences and the ability to distribute your content around the world in mere seconds, writing this paragraph could be one of the most influential things you ever do!
Introductory remarks
Today, we will share our view on the ongoing digitalization efforts in Deals.
Based on your interests and questions, we will jointly take a look at:
- overall trends,
- our approach,
- selected case studies and solutions,
- how you can realize quick wins on your digital journey.
While we invite you to raise your questions and express your comments verbally and engage in direct discussions with us anytime, you can also use Slido to submit your contributions.
In addition, we will conduct a number of polls as we are excited to understand your views and perspectives.
We kindly ask you to grant “presenter rights” to all PwC colleagues dialed in, as we might switch between presenters to share screen content.
